Navigation Links
$10,000 ISSAC Award for Innovation Presented to MIT PhD
Date:7/21/2009

LEXINGTON, Mass., July 21 /PRNewswire/ -- Heejin Lee, an MIT PhD and scientist, was awarded the prestigious 2009 IAI Award for his work on a silicone-based combination product recently launched by TARIS Biomedical.

The ISSAC Award for Innovation recognizes and promotes the achievements of biomedical scientists, designers, engineers and other researchers involved in the development of silicone-based combination products. Combination products are a new FDA defined category of implantable medical devices that release drugs into the body in a controlled manner. Combination products represent a new and rapidly expanding area of life-saving and life-enhancing technology.

The award-winning device is designed to function like a pump, using osmotic pressure to release drugs into the bladder. The size of the device, which is made with silicone and nickel alloy wire, is about that of a paper clip and shaped like a pretzel. The device is inserted in a short catheter-based procedure in a doctor's office. Once implanted, the system is designed to deliver drugs into the bladder for a specific period of time. The device is removed by conventional, non-surgical procedures after a few weeks. The technology is based on research performed by internationally renowned MIT scientists Michael Cima and Robert Langer.

Bladder diseases affect 50 million people in the U.S. alone, and delivering drugs to the bladder is tricky business. The current options include oral tablets, which must travel through the body to get to the bladder and can cause side effects in other organs. Some bladder diseases are treated with individual infusions or injections of a drug. But there are limits to how much of the drugs can be pumped into the body in one sitting, and patients typically must return to their doctor for each dose. A combination product delivers drugs directly to the bladder, in controlled amounts over a defined period of time, which represents a leap forward from the limitations of the current treatment options.

About TARIS Biomedical

TARIS Biomedical Inc. is a specialty pharmaceutical company with deep expertise in therapeutics and drug-delivery convergence products. For more information, visit http://www.tarisbiomedical.com .

About ISSAC Medical

ISSAC Medical is the world's premier manufacturer of silicone-based drug-eluting products and medical devices. The company provides a full range of services, including fabrication, assembly, packaging, and sterilization of silicone-based medical devices and device components. For more information, visit http://www.issacmedical.com

Photo: http://www.ereleases.com/pr/IAI-Award.jpg

ISSAC Award winner Heejin Lee is presented with a check for $10,000; Left to right: Cheryl Elkins (VP Taris), Heejin Lee, Christine Bunt (COO Taris), and Rob Grant (ISSAC Medical)

    Contact:

    Paul Mazelin, Marketing Director
    Specialty Silicone Fabricators
    Email: paul.mazelin@ssfab.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE ISSAC Medical
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Win a $10,000 Education Fund for Your Miracle Child
2. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
3. GeneNews CSO Dr. CC Liew awarded state honour by the Government of Malaysia
4. Mirus Bio Awarded Grants & Contracts of Over $5 Million
5. The Debiopharm Life Sciences Award Goes to Dr Nusser for his Outstanding Research in Neuroscience
6. ICx Awarded $1.5 M Contract by Department of Homeland Security for Development of Next Generation Bio Aerosol Systems
7. Miaxis Biometrics Named as Red Herring 100 Asia Award Winner for 2007
8. Richard Schulz Receives the Coveted GCPj Award for Best Clinical Researcher of the Year
9. Preclinical Research on Coronary Stent with CeloNova BioSciences Polyzene(R)- F Nanocoating Receives Award at CIRSE 2007
10. Hyaluron Contract Manufacturing Named a 2007 Economic Impact Award Finalist
11. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)...   Sienna Biopharmaceuticals, Inc. , a privately held, ... Richard Peterson will join the company as ... who brings more than two decades of global financial ... retiring at the end of April but will continue ... Sienna from Novan, Inc., where he served as Chief ...
(Date:3/23/2017)... Research and Markets has announced the addition of the ... ... The Global Market for Bioproducts Should Reach $714.6 Billion by ... 8.9%, This research report quantifies the two ... segments: bio-derived chemicals, biofuels, pharmaceuticals (biodrugs and herbal/botanicals), biocomposite materials, ...
(Date:3/23/2017)... March 23, 2017  BioPharmX Corporation (NYSE MKT: ... the dermatology market, today reported financial results for ... and will provide an update on the company,s ... "We are pleased to report that ... BioPharmX," said President Anja Krammer. "We achieved key ...
(Date:3/23/2017)... New York , March 23, 2017 ... blood plasma products and derivatives market is fragmented due to the presence ... players, such as Proliant, Thermo Fisher , and Sigma-Aldrich, compete ... leader, these three companies, collectively, held more than 76% of this ... ...
Breaking Biology Technology:
(Date:3/2/2017)... 2, 2017 Australian stem cell and regenerative ... has signed an agreement with the Monash Lung Biology ... Discovery Institute and Department of Pharmacology at Monash University, ... preclinical study to support the use of Cymerus™ mesenchymal ... Asthma is a chronic, long term lung ...
(Date:2/27/2017)... --  Strategic Cyber Ventures , the industry,s first cybersecurity ... million investment in  Polarity , the first commercial human ... based and is led by cybersecurity veterans Tom ... Gula , also a longtime cybersecurity veteran and founder ... A round of funding. This new funding will be ...
(Date:2/21/2017)... LONDON , February 21, 2017 ... um 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr ... es einige Hindernisse zu überwinden gilt, um diese Prognose ... ... unter anderem die Mobilisierung der finanziellen Mittel für die ...
Breaking Biology News(10 mins):